Clinical Validation
Clinical validation efforts are strengthened with Mayo Clinic’s vast clinical and phenotypic information across the outpatient and inpatient continuum.
Customized Validation of Molecular Targets and Lead Compounds
Mayo Validation Support Services provides a menu of services to assist in customized validation of promising gene targets, biomarkers, assays and lead compounds. These services include high-quality, well-annotated biospecimens, combined with comprehensive clinical data from Mayo Clinic’s integrated practice.
Validation technologies include:
- Specimen preparation, slides/staining, PBMCs and multiple formats
- Molecular and protemic testing
- Conversion technology for haploid mutation analysis
Comprehensive Validation With Patient Focus
While genomic and proteomic discoveries are revolutionizing development efforts, only those which have a clinically meaningful benefit to patients will enjoy success. Mayo Validation Support Services helps you select and focus on clinically useful technologies—and exclude those targets or compounds for which problems can be anticipated.
